Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-02-26 @ 6:53 AM
Study NCT ID:
NCT02356094
Status:
UNKNOWN
Last Update Posted:
2015-02-05
First Post:
2015-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Posterior Cornea in Primary Open Angle Glaucoma
Sponsor:
Centro Hospitalar do Baixo Vouga
Organization:
Study Overview
Official Title:
Posterior Cornea in Primary Open Angle Glaucoma
Status:
UNKNOWN
Status Verified Date:
2015-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Characterization of posterior corneal changes in primary open angle glaucoma patients, using Scheimpflug examination.
Detailed Description:
A cohort of primary open angle glaucoma (POAG) patients is submitted to Scheimpflug Pentacam examination. The results are compared with a control group of age and central corneal thickness matched healthy subjects
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: